Your browser doesn't support javascript.
loading
Pre- and Post-Injection Needle Pain in Patients Undergoing First Intracavernosal Injection.
Baird, Bryce; Wajswol, Ethan; Ericson, Christian; Anderson, Augustus; Broderick, Gregory.
Affiliation
  • Baird B; Department of Urology, Mayo Clinic Florida, Jacksonville, FL, USA. Electronic address: baird.bryce@mayo.edu.
  • Wajswol E; Department of Urology, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Ericson C; Department of Urology, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Anderson A; School of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
  • Broderick G; Department of Urology, Mayo Clinic Florida, Jacksonville, FL, USA.
J Sex Med ; 19(4): 590-593, 2022 04.
Article in En | MEDLINE | ID: mdl-35227620
ABSTRACT

BACKGROUND:

Intracavernosal injections (ICI) are a well-established treatment option for men with erectile dysfunction (ED); however, the anticipation of pain with injection remains a significant barrier to the use of ICI.

AIM:

To evaluate the patient-anticipated degree of pain versus the experienced degree of pain pre- and post-ICI in men undergoing their first injection with an erectile agent.

METHODS:

We studied 51 patients who underwent their first ICI in our men's health clinic. Anticipated needle-associated pain was judged with a pre-injection score, and pain experienced during the injection was judged with a post-injection score. All patients graded their pre- and post-ICI pain using a standard 10-point scale (0-10).

OUTCOMES:

Pre- and post-ICI pain was defined with the visual analogue scale (0-10) in men undergoing their first penile injection.

RESULTS:

Medians and interquartile ranges (IQRs) of the patients' age [65 years (54.5-68.0)], pre-injection pain [5 (4-7)], and post-injection pain [1 (1-2)] were recorded. Most men in the study had erectile dysfunction (68.6%) and/or Peyronie's Disease (64.7%). The average pre-injection prediction pain score was 5.45 ± 2.15; the average post-injection perceived pain score was 1.20 ± 0.73. Thus, there was an average discrepancy of over 4 points in predicted pain vs perceived pain. A paired t-test was performed which showed a statistically significant difference between pre- and post-injection scores (P < .05). A Wilcoxson Signed Rank Test showed statistical significance in the difference between pre- and post-injection pain scores (P < .05). CLINICAL IMPLICATIONS ICI is a safe, effective treatment for patients with ED and is associated with significantly less pain than is anticipated by patients. STRENGTHS &

LIMITATIONS:

This is the first report to describe the discrepancy between pre-ICI anticipated pain and post-ICI experienced pain. Limitations include an overall small sample size.

CONCLUSION:

Patients experience significantly less pain with ICI than they anticipate having. This represents an important factor to consider when counseling patients about available ED treatments. Baird B, Wajswol E, Ericson C et al. Pre- and Post-Injection Needle Pain in Patients Undergoing First Intracavernosal Injection. J Sex Med 2022;19590-593.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Penile Induration / Erectile Dysfunction Type of study: Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Journal: J Sex Med Journal subject: GINECOLOGIA / MEDICINA REPRODUTIVA / UROLOGIA Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Penile Induration / Erectile Dysfunction Type of study: Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Journal: J Sex Med Journal subject: GINECOLOGIA / MEDICINA REPRODUTIVA / UROLOGIA Year: 2022 Type: Article